Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 205

1.

Protocol for Get Moving: a randomised controlled trial to assess the effectiveness of three minimal contact interventions to promote fitness and physical activity in working adults.

Cooper AJ, Dearnley K, Williams KM, Sharp SJ, van Sluijs EM, Brage S, Sutton S, Griffin SJ.

BMC Public Health. 2015 Mar 27;15(1):296. [Epub ahead of print]

2.

Ureteroscopy for Paediatric Renal Tract Stones - Outcomes from a Tertiary European Centre.

Chedgy EC, Griffin SJ, Dyer JP, Somani BK.

Urol Int. 2015 Mar 21. [Epub ahead of print]

PMID:
25823558
3.

Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.

Echouffo-Tcheugui JB, Simmons RK, Prevost AT, Williams KM, Kinmonth AL, Wareham NJ, Griffin SJ.

Ann Fam Med. 2015 Mar;13(2):149-57. doi: 10.1370/afm.1737.

4.

Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial.

Tao L, Wilson EC, Wareham NJ, Sandbaek A, Rutten GE, Lauritzen T, Khunti K, Davies MJ, Borch-Johnsen K, Griffin SJ, Simmons RK.

Diabet Med. 2015 Feb 6. doi: 10.1111/dme.12711. [Epub ahead of print]

PMID:
25661661
5.

Impact of regulatory interventions to reduce intake of artificial trans-fatty acids: a systematic review.

Hendry VL, Almíron-Roig E, Monsivais P, Jebb SA, Neelon SE, Griffin SJ, Ogilvie DB.

Am J Public Health. 2015 Mar;105(3):e32-42. doi: 10.2105/AJPH.2014.302372. Epub 2015 Jan 20. Review.

PMID:
25602897
6.

Healthy behaviours and 10-year incidence of diabetes: a population cohort study.

Long GH, Johansson I, Rolandsson O, Wennberg P, Fhärm E, Weinehall L, Griffin SJ, Simmons RK, Norberg M.

Prev Med. 2015 Feb;71:121-7. doi: 10.1016/j.ypmed.2014.12.013. Epub 2014 Dec 19.

7.

Understanding perceived risk of type 2 diabetes in healthy middle-aged adults: a cross-sectional study of associations with modelled risk, clinical risk factors, and psychological factors.

Godino JG, van Sluijs EM, Sutton S, Griffin SJ.

Diabetes Res Clin Pract. 2014 Dec;106(3):412-9. doi: 10.1016/j.diabres.2014.10.004. Epub 2014 Oct 24.

8.

Sleep duration and cardiometabolic risk factors among individuals with type 2 diabetes.

Cooper AJ, Westgate K, Brage S, Prevost AT, Griffin SJ, Simmons RK.

Sleep Med. 2015 Jan;16(1):119-25. doi: 10.1016/j.sleep.2014.10.006. Epub 2014 Oct 23.

PMID:
25439076
9.

Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial.

Simmons RK, Carlsen AH, Griffin SJ, Charles M, Christiansen JS, Borch-Johnsen K, Sandbaek A, Lauritzen T.

Diabet Med. 2014 Dec;31(12):1577-85. doi: 10.1111/dme.12574. Epub 2014 Sep 29.

10.

Role of simulation in training the next generation of endoscopists.

Blackburn SC, Griffin SJ.

World J Gastrointest Endosc. 2014 Jun 16;6(6):234-9. doi: 10.4253/wjge.v6.i6.234. Review.

11.

Awareness of physical activity in healthy middle-aged adults: a cross-sectional study of associations with sociodemographic, biological, behavioural, and psychological factors.

Godino JG, Watkinson C, Corder K, Sutton S, Griffin SJ, van Sluijs EM.

BMC Public Health. 2014 May 2;14:421. doi: 10.1186/1471-2458-14-421.

12.
13.

Which behavior change techniques are associated with changes in physical activity, diet and body mass index in people with recently diagnosed diabetes?

Hankonen N, Sutton S, Prevost AT, Simmons RK, Griffin SJ, Kinmonth AL, Hardeman W.

Ann Behav Med. 2015 Feb;49(1):7-17. doi: 10.1007/s12160-014-9624-9.

14.

Do improvements in dietary behaviour contribute to cardiovascular risk factor reduction over and above cardio-protective medication in newly diagnosed diabetes patients?

Cooper AJ, Schliemann D, Long GH, Griffin SJ, Simmons RK; ADDITION-Cambridge study team.

Eur J Clin Nutr. 2014 Oct;68(10):1113-8. doi: 10.1038/ejcn.2014.79. Epub 2014 May 7.

15.

Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study.

Sandbæk A, Griffin SJ, Sharp SJ, Simmons RK, Borch-Johnsen K, Rutten GE, van den Donk M, Wareham NJ, Lauritzen T, Davies MJ, Khunti K.

Diabetes Care. 2014 Jul;37(7):2015-23. doi: 10.2337/dc13-1544. Epub 2014 May 1.

PMID:
24784827
16.

Multiple behaviour change intervention and outcomes in recently diagnosed type 2 diabetes: the ADDITION-Plus randomised controlled trial.

Griffin SJ, Simmons RK, Prevost AT, Williams KM, Hardeman W, Sutton S, Brage S, Ekelund U, Parker RA, Wareham NJ, Kinmonth AL; ADDITION-Plus study team.

Diabetologia. 2014 Jul;57(7):1308-19. doi: 10.1007/s00125-014-3236-6. Epub 2014 Apr 24.

17.

Physical activity, sedentary time and gain in overall and central body fat: 7-year follow-up of the ProActive trial cohort.

Golubic R, Wijndaele K, Sharp SJ, Simmons RK, Griffin SJ, Wareham NJ, Ekelund U, Brage S; ProActive Study Group.

Int J Obes (Lond). 2015 Jan;39(1):142-8. doi: 10.1038/ijo.2014.66. Epub 2014 Apr 15.

18.

Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial.

Black JA, Sharp SJ, Wareham NJ, Sandbæk A, Rutten GE, Lauritzen T, Khunti K, Davies MJ, Borch-Johnsen K, Griffin SJ, Simmons RK.

Br J Gen Pract. 2014 Apr;64(621):e208-16. doi: 10.3399/bjgp14X677833.

19.

Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals.

Finucane FM, Sharp SJ, Hatunic M, Sleigh A, De Lucia Rolfe E, Aihie Sayer A, Cooper C, Griffin SJ, Wareham NJ.

Diabetol Metab Syndr. 2014 Mar 26;6(1):43. doi: 10.1186/1758-5996-6-43.

20.

Glycated hemoglobin measurement and prediction of cardiovascular disease.

Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Thompson A, Sarwar N, Willeit P, Ridker PM, Barr EL, Khaw KT, Psaty BM, Brenner H, Balkau B, Dekker JM, Lawlor DA, Daimon M, Willeit J, Njølstad I, Nissinen A, Brunner EJ, Kuller LH, Price JF, Sundström J, Knuiman MW, Feskens EJ, Verschuren WM, Wald N, Bakker SJ, Whincup PH, Ford I, Goldbourt U, Gómez-de-la-Cámara A, Gallacher J, Simons LA, Rosengren A, Sutherland SE, Björkelund C, Blazer DG, Wassertheil-Smoller S, Onat A, Marín Ibañez A, Casiglia E, Jukema JW, Simpson LM, Giampaoli S, Nordestgaard BG, Selmer R, Wennberg P, Kauhanen J, Salonen JT, Dankner R, Barrett-Connor E, Kavousi M, Gudnason V, Evans D, Wallace RB, Cushman M, D'Agostino RB Sr, Umans JG, Kiyohara Y, Nakagawa H, Sato S, Gillum RF, Folsom AR, van der Schouw YT, Moons KG, Griffin SJ, Sattar N, Wareham NJ, Selvin E, Thompson SG, Danesh J.

JAMA. 2014 Mar 26;311(12):1225-33. doi: 10.1001/jama.2014.1873.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk